SCHEMBL28115401

SCHEMBL28115401

CN(Cc1ccccc1)C1C[C@H]2CC(O)C[C@H]2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.50
JAK2 O60674 1/20 0.48
JAK1 P23458 1/20 0.48
NAAA Q02083 2/20 0.46
GRIN2B Q13224 1/20 0.44
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
AGTR2 P50052 2/20 0.41
HRH4 Q9H3N8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
AOC3 Q16853 1/20 0.40
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28115399 1.00 SLC18A3 (0.50) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL29338809 0.80 SLC18A3 (0.54) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL10039726 0.80 NAAA (0.46) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL27098391 0.79 NAAA (0.50) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL28115404 0.79 JAK2 (0.50) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL28115405 0.79 JAK2 (0.50) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL23950410 0.77 NAAA (0.49) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL31715951 0.77 NAAA (0.49) SLC18A3JAK2JAK1NAAAGRIN2B
SCHEMBL28568037 0.77 JAK2 (0.64) SLC18A3JAK2JAK1NAAAAGTR2
SCHEMBL28568035 0.77 JAK2 (0.64) SLC18A3JAK2JAK1NAAAAGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106336406-B Having beta2Octahydropentalene derivatives with receptor agonistic and M receptor antagonistic activity and their medical use 四川海思科制药有限公司 2020-01-03 CN disclosed
CN-106336406-A Octahydrocyclopentadiene derivative with beta2 receptor agonisis and M receptor antagonism activity, and use thereof in medicines 四川海思科制药有限公司 2017-01-18 CN disclosed